SCHEMBL3848849

SCHEMBL3848849

Cc1cc(-c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4C(F)(F)F)cc23)on1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.35
PIK3CA P42336 1/20 0.34
ACVR1 Q04771 4/20 0.33
EGLN2 Q96KS0 1/20 0.33
GRM4 Q14833 1/20 0.32
BRD4 O60885 2/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
MAPKAPK2 P49137 1/20 0.31
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
AAK1 Q2M2I8 1/20 0.30
SLC22A12 Q96S37 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
TGFBR1 P36897 2/20 0.30
MAPK14 Q16539 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846938 0.80 SLC22A12 (0.38) PIK3CAACVR1GRM4USP2ALDH1A1
SCHEMBL3846598 0.79 PIK3CA (0.33) PIK3CAACVR1GRM4BRD4MAPKAPK2
SCHEMBL3851426 0.79 ATM (0.36) PIK3CAACVR1GRM4AAK1
SCHEMBL3853751 0.78 CA12 (0.40) PIK3CAACVR1GRM4AAK1SLC22A12
SCHEMBL3847393 0.77 PIK3CA (0.37) PIK3CAACVR1GRM4KDM4EUSP2
SCHEMBL3846231 0.76 MAPKAPK2 (0.46) METKDM4EUSP2ALDH1A1TSHR
SCHEMBL3847491 0.76 CYP2C19 (0.45) METPIK3CAACVR1USP2ALDH1A1
SCHEMBL5854358 0.75 EGLN2 (0.35) METPIK3CAACVR1EGLN2BRD4
SCHEMBL3854061 0.75 SLC22A12 (0.33) PIK3CAACVR1GRM4MAPKAPK2SLC22A12
SCHEMBL3850354 0.74 NCF1 (0.48) ACVR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed